These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine. Nguyen-Dumont T; Myszka A; Karpinski P; Sasiadek MM; Akopyan H; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Kitsera N; Siekierzynska A; Southey MC BMC Med Genet; 2018 Jan; 19(1):12. PubMed ID: 29351780 [TBL] [Abstract][Full Text] [Related]
6. Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer. Kiiski JI; Pelttari LM; Khan S; Freysteinsdottir ES; Reynisdottir I; Hart SN; Shimelis H; Vilske S; Kallioniemi A; Schleutker J; Leminen A; Bützow R; Blomqvist C; Barkardottir RB; Couch FJ; Aittomäki K; Nevanlinna H Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15172-7. PubMed ID: 25288723 [TBL] [Abstract][Full Text] [Related]
10. Association of FANCM Mutations with Familial and Early-Onset Breast Cancer Risk in a South American Population. Morales-Pison S; Morales-González S; Fernandez-Ramires R; Tapia JC; Maldonado E; Calaf GM; Jara L Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835452 [TBL] [Abstract][Full Text] [Related]
11. A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy. Silvestri V; Rizzolo P; Zelli V; Valentini V; Zanna I; Bianchi S; Tibiletti MG; Varesco L; Russo A; Tommasi S; Coppa A; Capalbo C; Calistri D; Viel A; Cortesi L; Manoukian S; Bonanni B; Montagna M; Palli D; Radice P; Peterlongo P; Ottini L Breast; 2018 Apr; 38():92-97. PubMed ID: 29287190 [TBL] [Abstract][Full Text] [Related]
12. Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants. Lim BWX; Li N; Mahale S; McInerny S; Zethoven M; Rowley SM; Huynh J; Wang T; Lee JEA; Friedman M; Devereux L; Scott RJ; Sloan EK; James PA; Campbell IG J Natl Cancer Inst; 2023 Feb; 115(2):181-189. PubMed ID: 36315097 [TBL] [Abstract][Full Text] [Related]
14. Bi-allelic Recessive Loss-of-Function Variants in FANCM Cause Non-obstructive Azoospermia. Kasak L; Punab M; Nagirnaja L; Grigorova M; Minajeva A; Lopes AM; Punab AM; Aston KI; Carvalho F; Laasik E; Smith LB; ; Conrad DF; Laan M Am J Hum Genet; 2018 Aug; 103(2):200-212. PubMed ID: 30075111 [TBL] [Abstract][Full Text] [Related]
15. FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome. Kiiski JI; Fagerholm R; Tervasmäki A; Pelttari LM; Khan S; Jamshidi M; Mantere T; Pylkäs K; Bartek J; Bartkova J; Mannermaa A; Tengström M; Kosma VM; Winqvist R; Kallioniemi A; Aittomäki K; Blomqvist C; Nevanlinna H Int J Cancer; 2016 Dec; 139(12):2760-2770. PubMed ID: 27542569 [TBL] [Abstract][Full Text] [Related]
16. Whole exome sequencing and replication for breast cancer among Hispanic/Latino women identifies Nierenberg JL; Adamson AW; Hu D; Huntsman S; Patrick C; Li M; Steele L; Tong B; Shieh Y; Fejerman L; Gruber SB; Haiman CA; John EM; Kushi LH; Torres-Mejía G; Ricker C; Weitzel JN; Ziv E; Neuhausen SL medRxiv; 2023 Jan; ():. PubMed ID: 36747679 [TBL] [Abstract][Full Text] [Related]
17. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility. Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162 [TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition. García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859 [TBL] [Abstract][Full Text] [Related]
19. Evaluating 17 breast cancer susceptibility loci in the Nashville breast health study. Han MR; Deming-Halverson S; Cai Q; Wen W; Shrubsole MJ; Shu XO; Zheng W; Long J Breast Cancer; 2015 Sep; 22(5):544-51. PubMed ID: 24510657 [TBL] [Abstract][Full Text] [Related]
20. Correlation of FANCM expression with clinical factors in luminal B breast cancer. Wang Y; Wang J; Long F; Wang N; Zhang B; Han H; Wang Y Breast Cancer; 2018 Jul; 25(4):431-437. PubMed ID: 29388117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]